Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Hyo Jeong Hong0
Rohit Singh0
Date of Patent
March 28, 2017
Patent Application Number
14125021
Date Filed
June 8, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to a fusion protein resulting from the fusion of a cancer-specific antibody and an angiogenesis inhibitor, and relates to an anti-cancer composition including the same. More specifically, in the present invention, it is preferable that the cancer-specific antibody is trastuzumab or a fragment thereof, and the angiogenesis inhibitor is a VEGF-Trap. When the fusion protein according to the present invention is used, there are advantages in that angiogenesis and cancer cell growth can be effectively inhibited as compared to trastuzumab or VEGF-Trap, and side effects can also be reduced.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.